About Us
HOP is currently funded by the OHSU Knight Cancer Institute Cancer Early Detection Advanced Research Center (CEDAR). CEDAR is a research institute dedicated to identifying those at risk for cancer, detecting cancers early, and developing treatments that treat those early cancers. CEDAR was founded in 2017 and has earned a reputation as a world leader in early detection.
OHSU Knight Cancer Institute
The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center between Sacramento and Seattle—an honor earned only by the nation’s top cancer centers. It offers the latest treatments and technologies as well as hundreds of research studies and clinical trials.
The HOP mission aligns with the Knight Cancer Institute's vision of fostering an innovative infrastructure that generates transformative and diverse data across basic, translational, and population-based research programs. With an aspirational goal of serving all Oregonians, HOP aims to collect genetic and survey-based data to catalyze impactful research, creating actionable insights and advancing our shared commitment to a healthier Oregon.
HOP is also supported by a growing network of collaborators including:
- University of Oregon Center for Science Communication Research
- Providence Cancer Institute
- Kaiser Permanente Center for Health Research
- Oregon Health Authority (OHA)
Are you a researcher and interested in collaborating with HOP?
Meet the Healthy Oregon Project Team
HOP is supported by a team of community outreach specialists, scientists, institutional collaborators, and genetic counselors at OHSU dedicated to bridging the gaps in disease prevention, diagnosis, and treatment—driving health advancements for all Oregonians and beyond.
The project is led by two OHSU Knight Cancer Institute investigators:
Jackie Shannon,
Ph.D., R.D., M.P.H.
Dr. Shannon is the Associate Director of Community Outreach and Engagement at the OHSU Knight Cancer Institute and professor in the Division of Oncological Science at the School of Medicine. Her work focuses on the determinants of disease at the population level and the development of highly collaborative research that includes molecular, genetic, and epidemiologic endpoints. Dr. Shannon directs Community Engaged Research Program and co-directs the Knight Community Partnership Program and is Associate Director of the Oregon Clinical and Translational Research Institute.
Jonathan Brody,
Ph.D.
Dr. Brody is the Vice Chair of Research for the Department of Surgery and is the Assoc. Director of the Brenden-Colson Pancreatic Center for Patient Care. His lab focuses on aspects of pancreatic cancer, including developing ways to optimize targeted therapies used in clinics for pancreatic cancer. He is also a co-leader in a new research program that focuses on addressing disparities in pancreatic cancer in the Native American community in Oregon, including trying to set up a genetic registry for the Native American community. He was part of the initiative to democratize personalized medicine for pancreatic cancer, where the Know Your Tumor program sequenced individuals with pancreatic cancer in every state in the country. They showed that outcomes dramatically changed when patients’ tumors were sequenced and matched with personalized therapy.
Contact our study team at [email protected] with any questions.
Join the Healthy Oregon Project today!
